Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. (Q53559624)
Jump to navigation
Jump to search
scientific article published in May 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. |
scientific article published in May 2007 |
Statements
Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. (English)
1 reference
Hideo Tanaka
1 reference
Takuo Ito
1 reference
Taiichi Kyo
1 reference
Akiro Kimura
1 reference
1 May 2007
1 reference
78
1 reference
5
1 reference
389-398
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference